Stocksigma LogoStocksigma Logo

Ajanta Pharma Releases FY'26 Sustainability Report Highlighting Decarbonisation and Capacity Expansion

Ajanta Pharma submitted its voluntary FY'26 Sustainability Report, aligned with GRI Standards. Operational highlights include revenue rising 17% YoY to

Ajanta Pharma Releases FY'26 Sustainability Report Highlighting Decarbonisation and Capacity Expansion

Ajanta Pharma Ltd · Others (Uncategorized) · 30 Sept 2026, 2:57 pm

Ajanta Pharma Releases FY'26 Sustainability Report Highlighting Decarbonisation and Capacity Expansion Ajanta Pharma submitted its voluntary FY'26 Sustainability Report, aligned with GRI Standards. Operational highlights include revenue rising 17% YoY to ₹5,453 cr., supported by tripling liquid formulation capacity at Pithampur to 18mn bottles annually. On ESG metrics, Scope 1 emissions fell 47% to 3,364 tCO2e, while installed solar capacity reached 16.6 MW, meeting 34% of energy needs. R&D investments reached ₹252 cr. (4.6% of revenue), delivering 53 product launches globally. Zero fatalities, zero product recalls, and zero data breaches were reported during the fiscal.

Original exchange filing (PDF)

More announcements from Ajanta Pharma Ltd

All Ajanta Pharma Ltd announcements